Structure Therapeutics Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2f441a19-e600-4ace-b3d8-d1d86c8ae4f9/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-176.6M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-020562 |
| FY 2024 | $-158.2M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001826 |
| FY 2023 | $-102.8M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002791 |
| FY 2022 | $-52.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-002791 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).